Biogaia AB
STO:BIOG B
Biogaia AB
EPS (Diluted)
Biogaia AB
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Biogaia AB
STO:BIOG B
|
EPS (Diluted)
kr3
|
CAGR 3-Years
22%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
EPS (Diluted)
kr2
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
EPS (Diluted)
kr3
|
CAGR 3-Years
8%
|
CAGR 5-Years
1%
|
CAGR 10-Years
14%
|
|
|
Probi AB
STO:PROB
|
EPS (Diluted)
kr0
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-7%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
EPS (Diluted)
kr11
|
CAGR 3-Years
9%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
BioArctic AB
STO:BIOA B
|
EPS (Diluted)
-kr2
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Biogaia AB
Glance View
BioGaia AB engages in the development, marketing, and sale of probiotic products. The company is headquartered in Stockholm, Stockholm. The firm develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The firm operates worldwide.
See Also
What is Biogaia AB's EPS (Diluted)?
EPS (Diluted)
3.5
SEK
Based on the financial report for Dec 31, 2024, Biogaia AB's EPS (Diluted) amounts to 3.5 SEK.
What is Biogaia AB's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
10%
Over the last year, the EPS (Diluted) growth was -4%. The average annual EPS (Diluted) growth rates for Biogaia AB have been 22% over the past three years , 10% over the past five years .
You don't have any saved screeners yet